Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001012975-20-000511
Filing Date
2020-05-29
Accepted
2020-05-29 17:04:46
Documents
1
Effectiveness Date
2020-05-29
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.1: Section 3(c)(1)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 8088
  Complete submission text file 0001012975-20-000511.txt   9264
Mailing Address 515 MADISON AVENUE, SUITE 2701 NEW YORK NY 10022
Business Address 515 MADISON AVENUE, SUITE 2701 NEW YORK NY 10022 212-752-2226
Health Catalyst Capital II, L.P. (Filer) CIK: 0001777452 (see all company filings)

EIN.: 841769755 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-340653 | Film No.: 20929071